Found: 52
Select item for more details and to access through your institution.
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1108, doi. 10.1007/s10637-015-0269-8
- By:
- Publication type:
- Article
Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 2, p. 161, doi. 10.1007/s10637-006-9007-6
- By:
- Publication type:
- Article
Copy Number Variation in Inflammatory Breast Cancer.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1086, doi. 10.3390/cells12071086
- By:
- Publication type:
- Article
Breast Conservation Surgery Achieving ≥ 2 mm Tumor-Free Margins Results in Decreased Local-Regional Recurrence Rates.
- Published in:
- Breast Journal, 2006, v. 12, n. 1, p. 28, doi. 10.1111/j.1075-122X.2006.00181.x
- By:
- Publication type:
- Article
Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 2, p. 1071, doi. 10.1159/000516760
- By:
- Publication type:
- Article
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113269
- By:
- Publication type:
- Article
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 289, doi. 10.1007/s10549-023-07195-5
- By:
- Publication type:
- Article
The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 1, p. 65, doi. 10.1007/s10549-022-06562-y
- By:
- Publication type:
- Article
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 641, doi. 10.1007/s10549-021-06292-7
- By:
- Publication type:
- Article
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 383, doi. 10.1007/s10549-020-05631-4
- By:
- Publication type:
- Article
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 303, doi. 10.1007/s10549-019-05238-4
- By:
- Publication type:
- Article
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 2, p. 297, doi. 10.1007/s10549-016-4006-6
- By:
- Publication type:
- Article
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 151, n. 3, p. 589, doi. 10.1007/s10549-015-3426-z
- By:
- Publication type:
- Article
Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.
- Published in:
- 2015
- By:
- Publication type:
- Report
Report on the PET/CT Image--Based Radiation Dosimetry of [<sup>18</sup>F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 4, p. 1, doi. 10.2967/jnmt.123.265623
- By:
- Publication type:
- Article
Report on the PET/CT Image–Based Radiation Dosimetry of [<sup>18</sup> F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 3, p. 204, doi. 10.2967/jnmt.123.265623
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: a Separate Entity.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 10, p. N.PAG, doi. 10.1007/s11912-019-0842-y
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone- PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone- PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosteronePET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 25, doi. 10.1634/theoncologist.2016-0229
- By:
- Publication type:
- Article
Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program.
- Published in:
- Breast Journal, 2020, v. 26, n. 9, p. 1688, doi. 10.1111/tbj.14030
- By:
- Publication type:
- Article
Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana‐Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
- Published in:
- Breast Journal, 2020, v. 26, n. 3, p. 384, doi. 10.1111/tbj.13509
- By:
- Publication type:
- Article
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25859-y
- By:
- Publication type:
- Article
Abraxane for Breast Cancer Therapy.
- Published in:
- American Health & Drug Benefits, 2009, v. 2, n. 3, p. S126
- By:
- Publication type:
- Article
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 23, p. 4085, doi. 10.1002/cncr.34441
- By:
- Publication type:
- Article
Prevalence of germline variants in inflammatory breast cancer.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 13, p. 2194, doi. 10.1002/cncr.32062
- By:
- Publication type:
- Article
Prevalence of germline variants in inflammatory breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 4, p. 444, doi. 10.1002/jcph.1559
- By:
- Publication type:
- Article
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0060-z
- By:
- Publication type:
- Article
Inflammatory breast cancer appearance at presentation is associated with overall survival.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6261, doi. 10.1002/cam4.4170
- By:
- Publication type:
- Article
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45835-6
- By:
- Publication type:
- Article
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
- Published in:
- AAPS Journal, 2017, v. 19, n. 5, p. 1411, doi. 10.1208/s12248-017-0101-9
- By:
- Publication type:
- Article
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 9, p. 2563, doi. 10.1245/s10434-017-5903-6
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 8, p. 2483, doi. 10.1245/s10434-015-4469-4
- By:
- Publication type:
- Article
Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 3, p. 811, doi. 10.1245/s10434-012-2640-8
- By:
- Publication type:
- Article
A Pharmacogenetic Prediction Model of Progression‐Free Survival in Breast Cancer using Genome‐Wide Genotyping Data from CALGB 40502 (Alliance).
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 3, p. 738, doi. 10.1002/cpt.1241
- By:
- Publication type:
- Article
Prospective clinical experience with research biopsies in breast cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- Report
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 97, n. 3, p. 311, doi. 10.1007/s10549-005-9125-4
- By:
- Publication type:
- Article
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 673, doi. 10.1007/s00280-021-04245-x
- By:
- Publication type:
- Article
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 441, doi. 10.1007/s00280-008-0754-2
- By:
- Publication type:
- Article
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 295, doi. 10.1007/s00280-004-0871-5
- By:
- Publication type:
- Article
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00555-w
- By:
- Publication type:
- Article
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00287-9
- By:
- Publication type:
- Article
Aggressive Subsets of Metastatic Triple Negative Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
- Published in:
- 2019
- By:
- Publication type:
- journal article